Home Transforming Care Advancing Clinical Excellence

Advancing Clinical Excellence

IHH Healthcare has embarked on a journey to improve clinical outcomes and enhance patient experience. Our wide-ranging initiatives include the introduction of clinical quality indicators, investing in new medical technologies, conducting service training and much more. Our efforts are aimed at ensuring patients feel cared for and costs are transparent at every touchpoint.

Our Holistic Approach to Exceptional Care

1. Tracking and measuring clinical performance and outcomes using clinical quality indicators

Since the implementation of our Value-Driven Outcomes (VDO) strategy in Q4 2020, we have doubled our number of VDO procedures from four to eight, hence providing significantly more patients with high-quality and cost-efficient healthcare services.
We started at a baseline of 113 clinical quality indicators (CQIs) in 2022 – our goal is to double this number by 2025. With growing CQIs, we can comprehensively and accurately track and monitor clinical performance and outcomes. An increase in CQIs usually co-relate with a lower outcome percentage, but IHH Healthcare is striving to achieve a 90% target by 2025. This commitment to excellence is at the core of our mission.

2. Providing continuous training for healthcare workers

We actively promote and facilitate knowledge sharing across and within our markets. By drawing from each other’s successes and experiences, we can enhance efficiency, effectiveness, and performance of the entire organisation.
 The IHH Quality Summit is an annual event that marks our quality journey and accomplishments, while also honouring individuals who devote themselves to delivering exceptional care. At our eighth Quality Summit held in 2023, delegates across the IHH network, academics and industry experts gathered to explore the theme of ‘Future of Care’. At the event, we also introduced the Operational Excellence Symposium aimed at developing a ground-up culture of continuous improvement in advancing healthcare management.
Separately in 2023, IHH hosted four medical symposiums in India, Türkiye and Singapore to unite professionals across IHH, fostering collaboration across business units and driving collective growth and innovation. The symposiums, covering topics including organ transplants, oncology, reproductive medicine and robotics-assisted surgery, were a platform for sharing medical best practices and key advances, introducing attendees to capabilities across IHH and building a community to facilitate knowledge exchange and patient referrals.

3. Investing in new medical technologies and clinical offerings

Mount Elizabeth Novena Hospital, a renowned private hospital in Singapore, opened its new Proton Therapy Centre in May 2023. The state-of-the-art facility is the first of its kind among private hospitals in Southeast Asia. It is also IHH’s most substantial single investment in medical technology. Proton therapy painlessly and precisely targets tumours in sensitive areas like the head or the neck while minimising damage and radiation exposure to surrounding healthy tissues and organs.
In other markets, we have also expanded our breadth and depth of medical services through the establishment of new treatment centres and introduction of advanced technologies such as artificial intelligence (AI) to improve disease diagnostics.

4. Adhering to a robust clinical governance framework

IHH’s commitment to excellent clinical and patient care is reflected in our adherence to a robust clinical governance framework. Through stringent quality standards, continuous monitoring, and evidence based practices, we foster a culture of accountability, transparency, and continuous improvement, ultimately benefiting patients and stakeholders alike. Through this steadfast commitment, we uphold IHH’s reputation as a leader in the healthcare industry.

IHH Healthcare Malaysia

Actinium treatment:
Targeted therapy for prostate cancer that delivers radiation directly to cancer cells while sparing surrounding tissues. Patients benefit from more effective treatment with fewer side effects. This is only offered at IHH hospitals in Malaysia.
CORI robotic system:
Technology to assist surgeons during joint replacement surgeries, offering greater precision and accuracy. Patients benefit from smaller incisions, reduced pain, faster recovery, and improved long-term outcomes.

IHH Healthcare Singapore

CAR T-cell therapy:
Groundbreaking immunotherapy that reprogrammes a patient’s immune cells to recognise and attack cancer cells. It offers hope to patients with certain types of leukemia and lymphoma that have been resistant to other treatments.
da Vinci Robotic Surgical System:
Surgical system that allows surgeons to perform minimally invasive procedures with greater precision and control. Patients benefit from smaller incisions, reduced pain, shorter hospital stays, and faster recovery. This reflects IHH’s expertise in minimally invasive surgery and its ability to offer superior outcomes for patients, available at Gleneagles Hospital Singapore.

Fortis (India)

Magnetic Resonance Linear Accelerator (MR LINAC):
Combines MRI scan with radiation therapy, allowing for real-time visualisation of tumors during treatment. Patients benefit from more precise radiation delivery and fewer side effects, available at Fortis Memorial Research Institute Gurgaon (FMRI).
Gamma Knife:
Non-invasive form of radiosurgery that delivers highly focused radiation to tumors in the brain. Patients benefit from precise tumor targeting and minimal damage to surrounding healthy tissue, available at FMRI.

Acibadem (Türkiye)

In-Vitro Fertilisation (IVF):
Some 2,200 embryos were transferred in 2023 with the rate of 59.5% positive pregnancies and 42.4% live births. This showcases our expertise in reproductive medicine and the ability to attract a diverse patient population seeking fertility solutions.

IHH Healthcare Malaysia

Digital PET CT and FAPI PET & CT scan:
IHH Malaysia is the first in Southeast Asia to offer FAPI PET/CT, which uses a new type of radioisotope. The advanced imaging techniques are used to detect and stage various types of cancers and patients benefit from more accurate tumor detection and treatment planning.
Mona Lisa for prostate biopsy:
Cutting-edge device used for prostate biopsy, providing more accurate and less invasive tissue sampling. Patients experience reduced discomfort, fewer complications, and faster recovery, ideal for patients seeking a less invasive approach to prostate care.

Gleneagles Hospitals (India)

MRI upgrade for Neurology Programme:
Implemented at Gleneagles BGS Hospital, Kengeri, Bengaluru.
Mammography system with 3D Tomosynthesis:
Advanced imaging technology used for breast cancer screening that captures multiple images of the breast from different angles, creating a three-dimensional view. This allows doctors to examine breast tissue layer by layer, making it easier to detect small abnormalities that may be hidden in a standard mammogram, available at Gleneagles HealthCity, Chennai.
Advanced cath labs:
Intravascular ultrasound (IVUS) imaging is now available at Gleneagles Hospital, Lakdi-Ka-Pul, Hyderabad. Additionally, at Parel, Mumbai, Gleneagles’ bi-plane cath lab allows for more advanced imaging.

Fortis (India)

MRIs for imaging services:
Commissioned at three Fortis hospitals (Anandapur, Kolkata; BG Road, Bengaluru; and Manesar, Gurugram).
Cath labs to enhance cardiac care:
Commissioned and under delivery at seven Fortis hospitals (Fortis Escorts Heart Institute; Greater Noida; Anandapur, Kolkata; Nagarbhavi, Bengalaru; Cunningham Road, Bengaluru; BG Road, Bengaluru; and Hiranandani Hospital, Vashi).

IHH Healthcare Singapore

Photon Counting CT:
Revolutionary imaging technology that offers higher resolution and lower radiation doses compared to traditional CT scans. Patients benefit from more detailed images and reduced radiation exposure, available at Mount Elizabeth Hospital.

IHH Healthcare Malaysia

MyHealth360:
A digital patient-centric mobile platform that streamlines patients’ healthcare journey so they can take charge of their health and well-being on one single app.

IHH Healthcare Singapore

Genomic Centre:
Advanced genetic testing and analysis to personalise patient care and treatment plans. Patients benefit from tailored treatment approaches based on their unique genetic makeup, available at Mount Elizabeth Novena Hospital.
New ambulatory care facility:
Centrally located at Woodleigh, Parkway MediCentre provides convenient and comprehensive outpatient care to the community.

Gleneagles Hong Kong

Oncology symposium:
Jointly organised by IHH Healthcare and Hong Kong University’s medical faculty departments to promote clinical collaboration, leveraging cuttingedge medical capabilities to advance cancer care and treatment options.

Celebrating Clinical Milestones

IHH is at the forefront of clinical excellence and compassionate patient care. Combining deep medical expertise with cutting-edge treatments, the organisation is elevating healthcare standards and enhancing lives worldwide. IHH's steadfast commitment to excellence underpins its mission to deliver impactful care that makes a meaningful difference in the lives of the communities it serves.